Formosan sweet-gum

Other Names

Beautiful sweetgumBeautiful sweetgum fruitBeautiful sweetgum resinChinese sweet gumChinese sweetgumFeng Xiang Guofeng xiang shuFormosa sweet gumFormosan gumFormosan sweetgumFructus LiquidambarisLiquidambar acerifoliaLiquidambar edentataLiquidambar formosanaLiquidambar formosana var. monticolaLiquidambar fruitLiquidambar maximowicziiLiquidambar rosthorniiLiquidambar taiwanianaLiquidambar tonkinensisLiquidambaris FructusLu Lu TongLulutongResina LiquidambarisSweetgum ball枫香树枫香脂 (Fengxiangzhi)楓香楓香樹路路通

Synopsis

Formosan Sweet-Gum (Liquidambar formosana Hance): A Comprehensive Reference

1. Identity and Botanical Description

1.1 Nomenclature and Taxonomy

Liquidambar formosana, commonly known as the Formosan gum, Chinese sweet gum, and Formosa sweet gum, is a species of tree in the family Altingiaceae native to East and Southeast Asia. The genus name Liquidambar comes from the Latin words liquidus meaning "liquid" and ambar meaning "amber," as two species in the genus produce a fragrant resin; the specific epithet formosana means "of the island of Formosa" (Taiwan). The authority citation is "Hance," referring to the botanist Henry Fletcher Hance, who formally described the species. A historical synonym encountered in TCM literature is Liquidambar taiwaniana Hance. The dried infructescence (compound fruit cluster) is known in Traditional Chinese Medicine (TCM) as Lù Lù Tōng (路路通), a name translating roughly to "all roads open," reflecting its broad traditional indications. The pharmaceutical Latin name for this fruit drug is Fructus Liquidambaris or Liquidambaris Fructus.

1.2 Morphological Characteristics

Liquidambar formosana is a large, native, deciduous tree that grows up to 30–40 m tall. The leaves are 10–15 cm wide and are three-lobed, unlike the five- to seven-lobed leaves of most American Liquidambar species. The foliage turns a very attractive red color in autumn. Leaves grow in an alternate arrangement and are simple, palmately veined, with serrated margins. The individual flowers of L. formosana are unisexual; however, both sexes can be found on the same plant (monoecious). Male flowers are in catkins, female flowers form dense spherical heads, and the fruit is burr-like because of the persistent styles. The common name "sweet gum" refers to an aromatic sweet balsam or gum that exudes from wounds to the tree.

1.3 Geographic Distribution

Liquidambar formosana grows mostly in woodland in warm temperate zones. It requires moist soil and can grow in light to no shade areas. It is found in Hong Kong, Central and Southern China, South Korea, Taiwan, Laos, and Vietnam.

1.4 Pharmacopoeial Status and Commercial Forms

After the fruits of Liquidambar formosana mature every winter, people gather their infructescences, remove impurities, dry them, and make them into Chinese herbal medicine. Various organs of the tree — the gum, fruits, barks, and leaves — have medicinal value and are commonly used in the pharmaceutical, food, and cosmetic industries. Liquidambaris Fructus is officially listed in the Pharmacopoeia of the People's Republic of China. Commercial preparations of the plant material include the whole dried fruit (sold as raw herb for decoction), standardized aqueous or ethanolic extracts of the fruit and leaf, dry extract powders, liquid tinctures, and essential oils obtained by hydrodistillation from both leaves and the oleoresin.

2. Traditional and Historical Use

2.1 First Recorded Appearance

Lu Lu Tong is a relatively practical and common Chinese herbal medicine, which first appeared in Ben Cao Gang Mu Shi Yi (a supplement to the Compendium of Materia Medica) in the 30th year of the Qianlong reign of the Qing Dynasty (1765 AD). According to Ben Cao Gang Mu Shi Yi, the medicinal nature of Lu Lu Tong is relatively neutral, with a bitter taste. The herb subsequently became integrated into mainstream TCM pharmacopoeia, with Liquidambaris Fructus's definite anti-liver-tumor effect being first recorded in the Compendium of Materia Medica.

2.2 Parts Used and Preparations in Traditional Medicine

When the bark of the Formosan sweet gum is damaged, it exudes an amber-colored sap. This sap, when collected and dried, can be used as a medicinal material. The fruits are also believed to have therapeutic properties, making this plant of significant medicinal value in traditional Chinese medicine.

In TCM, multiple plant parts have been employed:

Fruits (infructescences / Lu Lu Tong): The fruits were used in the treatment of arthritis, lumbago, oedema, oliguria, decreased milk production, and skin diseases.
Resin (balsam): The resin from the stems was used to treat bleeding boils, carbuncles, toothache, and tuberculosis. The trunk of the tree can be used for aromatic resin, and the extract of this resin was used to promote blood circulation and relieve pain.
Leaves: The leaves and roots were used in the treatment of cancerous growths.
Bark: The stem bark was used in the treatment of fluxes and skin diseases.

2.3 TCM Functional Classification and Indications

In TCM, Lu Lu Tong is classified as bitter and neutral in nature, and enters the Liver and Stomach meridians; its actions include promoting blood and Qi circulation, opening the middle Jiao, unblocking the channels, and promoting urination. Lu Lu Tong activates Qi and blood circulation and opens the channels and collaterals to treat pain, especially in the lower back and extremities. Lu Lu Tong also promotes urination to address dysuria and edema by draining excess water down and out of the body. Lu Lu Tong was additionally used to treat skin and nasal allergies such as itching, hives, and allergic rhinitis.

In TCM, various parts of the Formosan sweet-gum tree, particularly the resin (known as "lu lu tong"), have been used to address digestive issues such as abdominal pain, bloating, indigestion, and diarrhea. The traditional belief is that this ingredient aids in "promoting Qi circulation" and relieving stagnation in the digestive tract, which is thought to facilitate better digestion and alleviate discomfort.

2.4 Broader Cultural Uses

Liquidambar formosana is rare in cultivation, but in its native regions the wood is used for making tea chests and the leaves to feed silkworms. As a kind of natural pigment resource, L. formosana has great potential in food and related applications. A small group of people in East Asia has traditionally used the leaves of L. formosana as a dye for rice in festival food preparations.

3. Key Chemical Constituents and Active Compounds

3.1 Overview of Phytochemical Classes

Trace elements, volatile oils, terpenoids, phenylpropanoids, flavonoids, and tannins are the natural plant secondary metabolites known from the different organs of L. formosana. Diverse pharmacological activities of L. formosana are attributed to its phytochemical composition, especially volatile oils, phenylpropanoids, flavonoids, and terpenoids rich in leaves, resins, and fruits.

3.2 Triterpenoids (Fruits and Resin)

Recent natural product chemistry investigations found that Lu Lu Tong (LLT) mainly contains triterpenoids such as betulinic acid, oleanolic acid, and lantanolic acid. Other major constituents are tannins and flavan glycosides. A PubMed-indexed study on the chemical composition of Fructus Liquidambaris isolated and identified eleven compounds: beta-sitosterol, 3-oxo-11α,12α-epoxyleanan-28,13β-olide, 3-oxo-12α-hydroxy-oleanan-28,13β-olide, 3α-acetyloxy-25-hydroxyolean-12-en-28-oic acid, oleanolic acid, ursolic acid, daucosterol, betulonic acid, gallic acid, nonacosane, and n-triacontanoic acid.

A more comprehensive phytochemical study isolated thirteen triterpenoids from the fruits of L. formosana, identified as: betulonic acid, 28-nor-β-amyrenone, ambronal, betulin, oleanonic acid, ursonic acid, liquidambaric lactone, betulinic acid, epibetulinic acid, 3-oxo-12β-hydroxy-oleanan-28,13β-olide, hydroxyoleanonic lactone, 3α-acetoxy-25-hydroxyolean-12-en-28-oic acid, and arjunolic acid.

From the resin, four oleanane triterpenoids were isolated and identified as liquidambaric acid, oleanolic acid, 3α-acetoxy-25-hydroxy-olean-12-en-28-oic acid, and lantanolic acid. Of these, 3α-acetoxy-25-hydroxy-olean-12-en-28-oic acid (IC₅₀: 4.63 μM) and lantanolic acid (IC₅₀: 12.62 μM) exhibited strong inhibitory activity against the NFAT transcription factor.

3.3 Diterpenoids (Resin)

Liquidambarine D, a new labdane-type diterpenoid, and nineteen known compounds including five labdanes, eight abietanes, four pimaranes, and two nor-diterpenoids were isolated from the resin of Liquidambar formosana Hance. L. formosana oleoresin has been the source of several abietane diterpenoids and oleanane and lupane triterpenoids with cytotoxic, antifungal, glycogen phosphorylase inhibitory, and nuclear factor of activated T cell (NFAT) transcription factor inhibitory activities.

3.4 Sterols

Three compounds were isolated from the methanolic leaf extract and identified as beta-sitosterol, alpha-amyrin, and oleanonic acid; all were isolated from this plant for the first time in that study.

3.5 Flavonoids, Tannins, and Phenolic Acids

The leaves of L. formosana are a source of lignan glycosides and flavonoid glycosides as well as hydrolysable tannins, which is consistent with the antioxidant activity of L. formosana leaf extracts. Phenolic acids and flavonoids were identified as the major bioactive compounds of the L. formosana Hance leaf (LFHL). The ethyl acetate fraction (EAF) of leaf extracts gave the richest phenolics, condensed tannins, and hydrolysable tannins, which were 5.06-, 8.75-, and 3.57-fold those of the crude extract, respectively.

3.6 Volatile Oils and Essential Oil Constituents

The leaf essential oil of L. formosana from Taiwan has shown α-pinene (40.9%), β-pinene (24.8%), limonene (18.3%), α-phellandrene (8.9%), terpinen-4-ol (8.1%), and sabinene (5.6%) as the major components in one sample; another Taiwanese leaf essential oil sample had terpinen-4-ol (32.0%), β-pinene (18.0%), γ-terpinene (13.8%), and α-terpinene (9.7%) as the predominant compounds.

The fruit essential oil showed antifungal activity and was dominated by α-pinene (16.8%), (E)-caryophyllene (10.1%), τ-muurolol (8.3%), τ-cadinol (7.6%), β-pinene (6.7%), and sabinene (5.7%).

Lu Lu Tong (the dried fruit) also contains benzaldehyde, β-thujene, leaf alcohol, β-terpinene, α-thujene, α-pinene, β-pinene, amphene, α-terpinene, α-terpinol, citrene, γ-terpinene, terpinolene, thymol, geraniol, carvacrol, caryophyllene oxide, γ-eudesmol, isophytol, elemene, eicosane, and polyterpenes.

3.7 Shikimic Acid

Liquidambar species are notable natural sources of shikimic acid. In the pharmaceutical industry, shikimic acid from the Chinese star anise (Illicium verum) is used as a base material for the production of oseltamivir (Tamiflu). The low isolation yield of shikimic acid from Chinese star anise is blamed for the 2005 shortage of oseltamivir. Shikimic acid can also be extracted from the seeds of the sweetgum (Liquidambar styraciflua) fruit, abundant in North America, in yields of around 1.5%. The Formosan species (L. formosana) also contains shikimic acid, though its yield and practical utility as a pharmaceutical precursor have not been as extensively characterized as those of L. styraciflua. It has been widely claimed that sweetgum, as a natural source of shikimic acid, can be used as an analog to Tamiflu. However, this claim requires careful scrutiny: shikimic acid itself is only a chemical precursor — it must undergo multiple synthetic steps to become oseltamivir phosphate, and consuming plant material containing shikimic acid does not confer antiviral pharmacological activity comparable to the finished drug.

4. Pharmacological Activities and Scientific Evidence

Important note on evidence quality: The overwhelming majority of pharmacological studies on L. formosana are preclinical — conducted in cell culture (in vitro) or in rodent models (in vivo). Although preliminary studies of L. formosana are underway in different laboratories to use the antitumor, antithrombotic, anti-inflammatory, antimicrobial, antiviral, and antidepressant activities, these studies should be extended to humans in view of the medicinal nature of the plant. No completed randomized controlled trials (RCTs) in human subjects for L. formosana preparations were identified in the peer-reviewed literature searched for this article.

4.1 Anti-Inflammatory Activity

The fruit extract of L. formosana has shown anti-inflammatory activity. The anti-inflammatory mechanism of Liquidambaris Fructus has been investigated in a rodent model of rheumatoid arthritis. Rats with adjuvant-induced arthritis (AIA) were divided into four groups and administered petroleum ether extract of LF (PEL), ethyl acetate extract of LF (EEL), water extract of LF (WEL), or piroxicam (PIR) respectively for three weeks; two additional groups were used as normal and model controls. The clinical scores for arthritis, bone surface, synovial inflammation, and cartilage erosion were used to evaluate the therapeutic efficacy of each treatment. Serum IL-1β and TNF-α levels and the expression of NLRP3, IL-1β, and caspase-1 p20 in the synovial tissue of AIA rats were evaluated by ELISA and Western blot. Myrtenal and β-caryophyllene oxide, screened from PEL, could suppress the activation of NLRP3 inflammasome, thereby alleviating RA symptoms. Therefore, myrtenal and β-caryophyllene oxide were proposed as the active ingredients of LF that mediate its effects on arthritis symptoms. This work, published in BMC Complementary Medicine and Therapies in 2021, constitutes animal-level evidence only; no human clinical trials have confirmed these findings.

Additional in vitro work identified that certain diterpenoid compounds from L. formosana inhibited monocyte differentiation and production of pro-inflammatory cytokines IL-1β and TNF-α in the presence of LPS, with the conclusion that two triptoquinone molecules could be potential anti-inflammatory agents.

4.2 Antitumor / Cytotoxic Activity

Many pharmacological activities appear to be attributable to terpenoid and flavonoid constituents; terpenoids have been proposed as being responsible for the antitumor, antimicrobial, and antiviral activities that have been documented for L. formosana.

4.2.1 Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma (HCC) refers to one of the top 10 cancers in terms of morbidity and mortality globally. Liquidambaris Fructus (LF) generates a definite anti-liver-tumor effect as first recorded in the Compendium of Materia Medica; however, its effective substances and mechanism remain to be elucidated. A study employing serum pharmacochemistry and UPLC-QTOF-MS found that 11 prototype blood-transfused ingredients, including imperatorin and phellopterin, were detected. LF extract presented excellent impacts on enhancing quality of life, prolonging life cycle, reducing inflammatory reaction, protecting hepatocytes, improving body immunity, and killing liver tumor cells. Altogether 82 endogenous differential metabolites were found in metabolomics, suggesting that LFE can treat HCC by acting on key targets of the PTEN/PI3K/Akt pathway and fatty acid metabolism. This was a DEN-induced rat liver cancer model, not a human study.

Some triterpenoids from Liquidambar Fructus showed potent apoptosis-inducing abilities through the PI3K-AKT pathway. Mechanism studies suggested these compounds could regulate the mitochondrial pathway by up-regulating pro-apoptotic factors (Bad and Bax) and activating caspase-3 and caspase-9 to induce apoptosis. Further studies indicated that the pro-apoptotic effects were associated with PI3K-AKT pathway inhibition. Taken together, these studies provide evidence that triterpenoids from L. Fructus are promising candidates for hepatocellular carcinoma therapy. All cited work here is in vitro or animal-based.

A 2024 study of liquidambaric acid (betulonic acid) specifically found that liquidambaric acid (LDA), a pentacyclic triterpenoid compound derived from various plants including L. formosana, could inhibit HCC cell proliferation by arresting cell cycle and prompting apoptosis. LDA can also augment the therapeutic efficacy of regorafenib in HCC in vitro and in vivo.

4.2.2 Breast Cancer

Liquidambaris Fructus is the infructescence of Liquidambar formosana Hance and has been used to treat some breast diseases in Traditional Chinese Medicine. In previous studies, anti-breast cancer effects of triterpenoids in Liquidambaris Fructus were found. A network pharmacology and molecular docking study, published in BMC Complementary Medicine and Therapies in 2020, revealed that triterpenoids from Liquidambaris Fructus might exert anti-breast cancer effects by directly inhibiting multiple protein targets and signaling pathways, especially ErbB4 and EGFR and related pathways. This was a computational and cell-based study, not a clinical trial.

4.3 Antimicrobial Activity

L. formosana essential oils were screened for antimicrobial activity against a panel of potentially pathogenic bacteria and fungi and showed promising antimicrobial activities with minimum inhibitory concentration (MIC) ≤ 625 μg/mL. The oleoresin essential oils of Liquidambar formosana have potential therapeutic benefits; however, current research on L. formosana oleoresin essential oil is still in its early stages and its chemotypic characterization is undefined.

The sap has been used as an antimicrobial agent against Staphylococcus aureus, a methicillin-resistant bacterium. These data are in vitro. L. formosana resin has numerous medical applications in Asian folk medicine, such as being a promoter of blood circulation, an alleviator of blood stasis, an analgesic, and an anti-inflammatory and wound-healing agent.

4.4 Antiviral Activity

At a specific concentration of extract, cell viability against H1N1 influenza increased to 50%; at this same concentration, the relative activity of the virus was reduced to 25%. Thus, sweetgum trees are valuable resources for antiviral medications in that they contain shikimic acid and extracts that effectively inhibit the H1N1 virus. These results are from in vitro models only; no clinical antiviral efficacy in humans has been established.

4.5 Antioxidant Activity

L. formosana and compounds isolated therefrom include antioxidant actions among their reported pharmacological activities. L. formosana leaves are a strong antioxidant source and may either mitigate or prevent the generation of free radicals. All extracts exhibited excellent antioxidant activities and were superior to butylated hydroxytoluene (BHT, a synthetic antioxidant used as reference). The antioxidant activity and total phenolic (TP) and total flavonoid (TF) content of various extracts followed the same trend: ethanolic extract > water extract > acetone extract. This implied a good correlation between antioxidant activities and TP/TF content. All such data are in vitro.

4.6 Hypoglycemic and Anti-Glycation Activity

A study firstly investigating the ability of Liquidambar formosana Hance leaf (LFHL) against diabetes and diabetic complications fractionated the bioactive constituents with solvents at various polarities and measured the antioxidant, hypoglycemic, and anti-glycation activities, as well as the content of phenolics, flavonoids, hydrolysable tannins, and condensed tannins. The ethyl acetate fraction (EAF) gave the highest antioxidant, hypoglycemic, and anti-glycation activities. This work was conducted entirely in vitro (cell-free enzyme inhibition assays) and does not establish clinical efficacy in humans.

4.7 Antithrombotic / Antiplatelet Activity

Antithrombotic activity is documented as a key traditional indication and has received some preclinical investigation. 28-oleanolic acid type carboxyl triterpenoids from the extracts of L. formosana significantly inhibited ADP-induced platelet aggregation, suggesting that pentacyclic triterpenoids have anti-platelet aggregation activity. The main pharmacological actions of L. formosana and compounds isolated therefrom include antithrombotic, among other activities. As with other areas, this evidence is preclinical.

4.8 Antidepressant Activity

The main pharmacological actions of L. formosana and compounds isolated therefrom also include antidepressant actions. Details of specific study designs or mechanisms for this indication are not well characterized in the available literature.

5. Body Systems and Health Areas of Association

Based on both traditional use and the preclinical scientific evidence available, Liquidambar formosana preparations are associated with the following body systems and health areas:

Musculoskeletal and Connective Tissue: In TCM, LF has been used to treat joint pain, a common symptom of arthritis and rheumatism; however, a lack of pharmacological evidence has limited its applications in modern clinics.
Cardiovascular / Circulatory: L. formosana resin has been used as a promoter of blood circulation and an alleviator of blood stasis. Anti-platelet and antithrombotic activities have been documented in preclinical work.
Hepatic (Liver): Modern pharmacological studies demonstrate that LF possesses the functions of liver protection, anti-tumor, and anti-inflammation.
Oncology (Preclinical): Antitumor activity against hepatocellular carcinoma and breast cancer cell lines has been documented in vitro and in animal models.
Immune / Anti-inflammatory: NLRP3 inflammasome suppression, pro-inflammatory cytokine inhibition, and NFAT inhibition have all been proposed as mechanistic targets in preclinical work.
Metabolic / Endocrine: Hypoglycemic and anti-glycation activity has been shown in vitro using leaf extracts.
Urinary: Lu Lu Tong promotes urination to address dysuria and edema.
Skin: The bark has been used in treatment of skin diseases, and the fruits in treatment of skin diseases.
Respiratory: The resin has been used to treat skin problems, coughs, and ulcers.

6. Dosage Forms and Dosages Reported in Studies

No standardized, widely accepted human dose has been established for Liquidambar formosana or its preparations. Dosages described below are taken directly from the cited sources and relate to TCM practice or preclinical experimental protocols.

Dried fruit (decoction, TCM): TCM sources reference the dried infructescence for oral decoction, consistent with standard preparation of Chinese herbal materia medica. No specific human dose range was recoverable from peer-reviewed sources for this article.
Experimental animal dosing (arthritis study): Rats were administered petroleum ether extract of LF (PEL), ethyl acetate extract of LF (EEL), water extract of LF (WEL), or piroxicam (PIR) respectively for three weeks in a rodent model; specific mg/kg doses are not reproduced here as the source abstract did not fully detail them in the retrieved text.
Hepatocellular carcinoma model (animal): Serum pharmacochemistry and UPLC-QTOF-MS technologies were employed to explore the plasma of rats after intragastric administration of liquidambaris fructus extract (LFE), and a DEN-induced rat liver cancer model was used to investigate anti-tumor activity.
Essential oil (antimicrobial in vitro): The essential oils showed antimicrobial activities with MIC ≤ 625 μg/mL against pathogenic bacteria and fungi in vitro; this is a laboratory concentration, not a human dose.
Pharmaceutical listing in China: The fruit is listed in the Pharmacopoeia of the People's Republic of China, which specifies preparative standards. The Chinese Pharmacopoeia Commission has documented Lu Lu Tong formally, but specific dosage recommendations from that text were not directly accessible for citation here.

7. Safety Considerations

7.1 Contraindication in Pregnancy

Lu Lu Tong is contraindicated during pregnancy. This contraindication is well established in TCM sources and appears consistent with the herb's blood-moving, channel-opening properties, which are traditionally considered inappropriate during pregnancy.

7.2 Potential Suppression of Lactation

A research finding raises concern about one traditional indication: the study revealed that triterpenoids from Liquidambaris Fructus might exert anti-breast cancer effects by directly inhibiting multiple protein targets and signaling pathways, especially ErbB4 and EGFR. This study also brings up the hint that the traditional application of Liquidambaris Fructus on hypogalactia (insufficient milk production) should be reassessed systematically, because it might suppress rather than promote lactation by inhibiting the activity of ErbB4. This represents an important safety signal that conflicts with a traditional indication; it has not yet been fully investigated in humans.

7.3 Heavy Menstrual Bleeding

The antithrombotic and blood-circulating properties of Lu Lu Tong suggest caution in the setting of heavy menstrual bleeding. TCM retail sources note that the herb should not be used with heavy menstruation, a signal consistent with the antiplatelet activity documented preclinically.

7.4 State of Pharmacovigilance Data

Further research is required to isolate and identify more new compounds contributing to the pharmacological effects of L. formosana. The absence of large-scale human clinical trials means that comprehensive pharmacovigilance data, drug-herb interaction profiles, and definitive toxicological thresholds in humans remain largely undescribed in the peer-reviewed literature. Preliminary studies should be extended to humans in view of the medicinal nature of the plant.

7.5 Essential Oil and Oleoresin Safety

The oleoresin essential oils of Liquidambar formosana have potential therapeutic benefits; however, current research is still in its early stages and its chemotypic characterization is undefined. Variation in essential oil composition between geographical sources and chemotypes means that safety and efficacy conclusions drawn from one sample may not generalize to all commercial preparations.

7.6 Potential Cardiovascular Interactions

Given the antiplatelet/antithrombotic activity documented preclinically, interactions with anticoagulant or antiplatelet pharmaceutical drugs (e.g., warfarin, aspirin, clopidogrel) are plausible but have not been formally studied in humans. No peer-reviewed pharmacokinetic or drug interaction studies specific to L. formosana preparations were identified.

7.7 Quality and Identity Concerns

Generally, gray-brown or tan Lu Lu Tong with many beak-shaped small blunt spines and sharp spines on the surface is preferred as a quality indicator in the TCM trade. Adulteration with other dried fruit materials and variable extraction methodology can affect phytochemical content and, consequently, biological activity.

8. Overall Evidence Assessment

The scientific literature on Liquidambar formosana supports the following characterization of evidence strength by domain:

Phytochemistry: Strong — Multiple peer-reviewed studies have comprehensively characterized the major classes of secondary metabolites in fruits, resin, leaves, and bark.
Anti-inflammatory and anti-arthritic activity: Preliminary, animal-level — One well-designed rodent AIA study supports a mechanism via NLRP3 inflammasome suppression; no human trials exist.
Antitumor / cytotoxic activity: Preliminary, in vitro and animal-level — Cell-based and rodent studies show activity against HCC and breast cancer cell lines via PI3K-AKT, caspase, and receptor tyrosine kinase pathways; no clinical data exist.
Antimicrobial activity: Preliminary, in vitro only — Essential oils show MIC activity at laboratory concentrations; no human trials.
Antiviral activity: Preliminary, in vitro — Cell-based inhibition of H1N1; shikimic acid content does not confer direct antiviral activity equivalent to oseltamivir.
Antioxidant activity: Preliminary, in vitro — Consistently demonstrated in cell-free assays; clinical significance unknown.
Hypoglycemic activity: Very preliminary, in vitro only — Enzyme inhibition assays only; no animal or human data specific to this species.
Traditional uses (TCM): Historical/empirical — Well-documented since 1765 AD in TCM pharmacopoeias; rigorous clinical validation has not been performed.

Based on the foundation of chemical constituents and their possible contribution to the demonstrated efficacy of extracts obtained from L. formosana, new directions on quality control and application of this plant are suggested. L. formosana will be further developed for its medicinal and economic value, and thereby promote its cultivation. Further research is required to isolate and identify more new compounds contributing to the pharmacological effects.

References

Health Conditions

Health conditions that Formosan sweet-gum may help support.

No conditions available.

Body Systems

Body systems that Formosan sweet-gum may help support.

No body systems available.